Join to view full profile
9999 bonnockburnDeerfield, IL 60015
Dr. Nabhan is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Loyola Quinlan School of BuisnessMBA, Health Care Management, Magna Cum Laude, 2014 - 2016
McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 1999 - 2002
Loyola University Medical CenterResidency, Internal Medicine, 1995 - 1998
Damascus University Faculty of MedicineClass of 1991
Certifications & Licensure
IL State Medical License 1997 - 2029
IN State Medical License 1999 - 2027
WI State Medical License 1997 - 2027
FL State Medical License 2008 - 2026
CA State Medical License 2015 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
National Board of Physicians and Surgeons Hematology- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2015-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2015-2017
- CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2012, 2015-2017
Clinical Trials
Publications & Presentations
PubMed
- 5 citationsInhibition of PIM Kinase in Tumor-Associated Macrophages Suppresses Inflammasome Activation and Sensitizes Prostate Cancer to Immunotherapy.Amber N Clements, Andrea L Casillas, Caitlyn E Flores, Hope Liou, Rachel K Toth
Cancer Immunology Research. 2025-05-02 - 7 citationsStructurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic Subtypes.Justin Hwang, Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, Sharon Wu, Jason J Kwon
Clinical Cancer Research. 2025-03-03 - 20 citationsNatural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes.Nicholas A Zorko, Allison Makovec, Andrew Elliott, Samuel Kellen, John R Lozada
Prostate Cancer and Prostatic Diseases. 2025-03-01
Journal Articles
- Rethinking Clinical Trials Reform During the COVID-19 PandemicChadi Nabhan, Toni K Choueiri, JAMA Oncology
Abstracts/Posters
- Utilization of Immune Checkpoint Inhibitors for Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) in Oncology Community PracticesChadi Nabhan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Adverse Events in Elderly Hodgkin Lymphoma Patients Treated with Pembrolizumab or Nivolumab in the Real WorldChadi Nabhan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Efficacy of Therapies Following Venetoclax Discontinuation in CLL: Focus on B-Cell Receptor Signal Transduction Inhibitors and Cellular TherapiesChadi Nabhan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Frequency and causes of oncologists’ burnout in community practices.2019 ASCO Annual Meeting - 6/1/2019
- Patient-Reported Outcome Labeling for Malignant Hematology Drugs Approved in the United States: 2011-20172018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Treatment Patterns and Outcomes of Relapsed/Refractory Peripheral T-Cell Lymphoma (RR-PTCL) Patients Treated in the Community Oncology Setting2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Authored Content
- Rethinking Clinical Trials Reform During the COVID-19 PandemicAugust 2020
- Rethinking Clinical Trials Reform During the COVID-19 PandemicAugust 2020
Press Mentions
Caris Life Sciences to Showcase Research Highlighting the Clinical Value of Comprehensive Molecular Profiling at the American Association for Cancer Research Annual MeetingApril 14th, 2023- The Caris Precision Oncology Alliance Welcomes University of Chicago Medicine Comprehensive Cancer CenterMarch 8th, 2023
- Caris Life Sciences to Showcase Extensive Research with Leading Cancer Centers at ASCO Gastrointestinal Cancers Symposium 2023 Reflecting Its Commitment to Improving Outcomes for PatientsJanuary 18th, 2023
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: